{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:11:54Z","timestamp":1761675114604,"version":"3.44.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1053\/ob.1998.v179.a93122","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T10:23:48Z","timestamp":1092479028000},"page":"s68-s77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"S","title":["Myocardial infarction and stroke in young women: What is the impact of oral contraceptives?"],"prefix":"10.1053","volume":"179","author":[{"given":"Michael A","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ob.1998.v179.a93122_BIB1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.2.5599.199","article-title":"Investigation of relation between use of OCs and thromboembolic disease","volume":"2","author":"Vessey","year":"1968","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pds.2630020103","article-title":"Oral contraceptives and cardiovascular disease: an epidemiologic overview","volume":"2","author":"Thorogood","year":"1993","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1053\/ob.1998.v179.a93122_BIB3","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","author":"Farley","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB4","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91929-5","article-title":"Enhancement of factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen","volume":"346","author":"Bloemenkamp","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0140-6736(05)63015-2","article-title":"End of the line for the \u2033third-generation-pill\u201d controversy?","volume":"349","author":"Vandenbroucke","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB9","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)61657-1","article-title":"Oral contraceptives and venous thromboembolism [letter]","volume":"349","author":"Lewis","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB10","first-page":"627","article-title":"Risk of acute myocardial infarction and low-dose combined oral contraceptives [letter]","volume":"347","author":"Jick","year":"1996","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/bmj.312.7023.88","article-title":"Third generation oral contraceptives and risk of myocardial infarction: an international case-control study","volume":"312","author":"Lewis","year":"1996","journal-title":"BMJ"},{"year":"1982","series-title":"Epidemiologic research: principles and quantitative methods","author":"Kleinbaum","key":"10.1053\/ob.1998.v179.a93122_BIB12"},{"year":"1986","series-title":"Modern Epidemiology","author":"Rothman","key":"10.1053\/ob.1998.v179.a93122_BIB13"},{"key":"10.1053\/ob.1998.v179.a93122_BIB14","first-page":"13","article-title":"The risk of venous thromboembolism associated with low oestrogen oral contraceptives","volume":"1","author":"Farmer","year":"1995","journal-title":"J Obstet Gynaecol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0895-4356(96)00024-8","article-title":"Coronary heart disease mortality, morbidity, and case fatality in five east and west German cities 1985-1989","volume":"49","author":"Barth","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"suppl 1","key":"10.1053\/ob.1998.v179.a93122_BIB16","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1093\/ije\/18.3_Supplement_1.S118","article-title":"Cardiovascular disease risk factors, CHD morbiditiy and mortality in the Federal Republic of Germany","volume":"18","author":"Greiser","year":"1989","journal-title":"Int J Epidemiol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case fatality rates in 38 populations from 21 countries and four continents","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1053\/ob.1998.v179.a93122_BIB18","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF02026086","article-title":"Trends in mortality from cardiovascular and cerebrovascular disease","author":"La Vecchia","year":"1993","journal-title":"Soz Pr\u00e4ventivmed"},{"key":"10.1053\/ob.1998.v179.a93122_BIB19","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1056\/NEJM199412153312401","article-title":"A prospective study of venous thromboembolism after major trauma","volume":"331","author":"Geerts","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB20","first-page":"A301","article-title":"Die tiefe Venenthrombose","volume":"94","author":"Diehm","year":"1997","journal-title":"Dtsch \u00c4rztebl"},{"key":"10.1053\/ob.1998.v179.a93122_BIB21","unstructured":"M Lewis, The epidemiology of oral contraceptive use: a critical review of the studies on oral contraception and the health of young women, Am J Obstet Gynecol (In press)."},{"key":"10.1053\/ob.1998.v179.a93122_BIB22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/0895-4356(95)00516-1","article-title":"A multinational case-control study of cardiovascular disease and steroid hormone contraceptives: description and validation of methods","volume":"48","author":"Poulter","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pds.2630020105","article-title":"Trinational case-control study of oral contraceptives and health","volume":"2","author":"Spitzer","year":"1993","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1053\/ob.1998.v179.a93122_BIB24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1099-1557(199601)5:1<43::AID-PDS217>3.0.CO;2-M","article-title":"Transnational Case-control Study of Oral Contraceptives and Health: approved protocol revisions through September, 1995","volume":"5","author":"Lewis","year":"1996","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1053\/ob.1998.v179.a93122_BIB25","first-page":"187","article-title":"Kaiser Permanente medical care program: northern California and other regions","author":"Friedman","year":"1994"},{"key":"10.1053\/ob.1998.v179.a93122_BIB26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0895-4356(94)00137-F","article-title":"The VAMP research multi-purpose database in the UK","volume":"48","author":"Lis","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB27","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","article-title":"The UK General Practice Research Database","volume":"350","author":"Walley","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB28","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1053\/ob.1998.v179.a91674","article-title":"Thrombotic diseases in young women and the influence of oral contraceptives","volume":"179","author":"Lidegaard","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international multicentre case-control study","volume":"348","author":"Poulter","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB30","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1136\/bmj.315.7121.1502","article-title":"Oral contraceptives and the risk of thromboembolic stroke: results from the transnational study on oral contraceptives and the health of young women","volume":"315","author":"Heinemann","year":"1997","journal-title":"Br Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB32","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199612053352312","article-title":"Stroke in users of low-dose oral contraceptives [letter]","volume":"335","author":"Corolei","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(97)00204-7","article-title":"Thromboembolic stroke in young women: a European case-control study on oral contraceptives","volume":"57","author":"Heinemann","year":"1998","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB34","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives [letter]","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB35","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study","volume":"349","author":"Poulter","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.315.7109.679b","article-title":"Lowered risk of dying of heart attack with third generation pill may offset risk of dying of thromboembolism [letter]","volume":"315","author":"Lewis","year":"1997","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB37","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0029-7844(96)00351-1","article-title":"Myocardial infarction in users of low-dose oral contraceptives","volume":"88","author":"Sidney","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(97)00118-2","article-title":"The use of oral contraceptives and the occurrence of acute myocardial infarction in young women: results from the Transnational Study on Oral Contraceptives and the Health of Young Women","volume":"56","author":"Lewis","year":"1997","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(96)90432-8","article-title":"Safety of modern oral contraceptives [letter]","volume":"347","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB40","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/bmj.311.7013.1112","article-title":"Third generation oral contraceptive pills [editorial]","volume":"311","author":"MacRae","year":"1995","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB41","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1099-1557(199609)5:5<285::AID-PDS236>3.0.CO;2-T","article-title":"Could preferential prescribing and referral behaviour of physicians explain the elevated thrombosis risk found to be associated with third generation oral contraceptives?","volume":"5","author":"Heinemann","year":"1996","journal-title":"Pharmacoepidemiol Drug Safety"},{"key":"10.1053\/ob.1998.v179.a93122_BIB43","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1056\/NEJM199612123352407","article-title":"Management of venous thromboembolism","volume":"335","author":"Ginsberg","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB44","first-page":"A310","article-title":"Die tiefe Venenthrombose: Diagnostik und Therapie","volume":"94","author":"Diehm","year":"1997","journal-title":"Dtsch \u00c4rzteblatt"},{"key":"10.1053\/ob.1998.v179.a93122_BIB45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0010-7824(97)00002-4","article-title":"Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptives","volume":"55","author":"Weiss","year":"1997","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB46","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0010-7824(97)00001-2","article-title":"Risk of oral contraceptives and recency of market introduction","volume":"55","author":"Vandenbroucke","year":"1997","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0010-7824(97)90013-5","article-title":"Role of bias in observational studies on oral contraceptives","volume":"55","author":"Lewis","year":"1997","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bmj.2.5965.241","article-title":"Myocardial infarction in young women with special reference to oral contraceptive practice","volume":"2","author":"Mann","year":"1975","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.2.5965.245","article-title":"Oral contraceptives and death from myocardial infarction","volume":"2","author":"Mann","year":"1975","journal-title":"BMJ"},{"key":"10.1053\/ob.1998.v179.a93122_BIB50","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1471-0528.1991.tb15397.x","article-title":"Is oral contraceptive use still associated with an increased risk of fatal myocardial infarction? Report of a case-control study","volume":"98","author":"Thorogood","year":"1991","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB51","first-page":"541","article-title":"Further analyses of mortality in oral contraceptive users","volume":"1","author":"Royal College of General Practitioners' Oral Contraception Study","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB52","first-page":"94","article-title":"Risk factors for myocardial infarction in young women","volume":"30","author":"Mann","year":"1976","journal-title":"Br J Prev Soc Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB53","first-page":"430","article-title":"Relation between sex hormone binding globulin and d-norgestrel levels in plasma","volume":"86","author":"Victor","year":"1977","journal-title":"Acta Endocrinol"},{"key":"10.1053\/ob.1998.v179.a93122_BIB54","first-page":"256","article-title":"Structural requirements for optimal receptor binding of contraceptive progestogens","volume":"1","author":"Berginck","year":"1985","journal-title":"Adv Contracept"},{"key":"10.1053\/ob.1998.v179.a93122_BIB55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00001648-199601000-00017","article-title":"Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer","volume":"7","author":"Lipworth","year":"1995","journal-title":"Epidemiology"},{"key":"10.1053\/ob.1998.v179.a93122_BIB56","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0010-7824(89)90070-X","article-title":"Lipid metabolism and coagulation of two contraceptives: correlation to serum concentrations of levonorgestrel and gestodene","volume":"40","author":"Kjaer","year":"1989","journal-title":"Contraception"},{"key":"10.1053\/ob.1998.v179.a93122_BIB57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB58","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/01.CIR.76.3.515","article-title":"Review of lipid-lowering clinical trials in relation to observational epidemiologic studies","volume":"76","author":"Tyroler","year":"1987","journal-title":"Circulation"},{"key":"10.1053\/ob.1998.v179.a93122_BIB59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0038-1657547","article-title":"Oral contraceptives and thrombotic disease: risk of venous thromboembolism","volume":"78","author":"Helmerhorst","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1053\/ob.1998.v179.a93122_BIB60","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM198811173192004","article-title":"A prospective study of past use of oral contraceptive agents and risk of cardiovascular disease","volume":"319","author":"Stampfer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1053\/ob.1998.v179.a93122_BIB61","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(79)91205-4","article-title":"Oral-contraceptive use in relation to myocardial infarction","volume":"2","author":"Shapiro","year":"1979","journal-title":"Lancet"},{"key":"10.1053\/ob.1998.v179.a93122_BIB62","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.1978.03280410045016","article-title":"Oral contraceptives and nonfatal myocardial infarction","volume":"239","author":"Jick","year":"1978","journal-title":"JAMA"},{"key":"10.1053\/ob.1998.v179.a93122_BIB63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0010-7824(97)00026-7","article-title":"Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives","volume":"55","author":"Schwingl","year":"1997","journal-title":"Contraception"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937898005092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937898005092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:37:46Z","timestamp":1757583466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937898005092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["S0002937898005092"],"URL":"https:\/\/doi.org\/10.1053\/ob.1998.v179.a93122","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[1998,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial infarction and stroke in young women: What is the impact of oral contraceptives?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ob.1998.v179.a93122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}